Aortic & peripheral vascular disease

Illness Trajectories After Revascularization in Patients With Peripheral Artery Disease: A Unified Approach to Understanding the Risk of Major Amputation and Death

CirculationPublished Retrospective cohort study

Authors' conclusion

Although mortality increased with age, the study highlights patients <60 years of age were at increased risk of major amputation, particularly after nonelective revascularization.

Study context

Population
Patients ≥50 years undergoing lower limb revascularization for PAD in England, April 2013 to March 2020
Participants
94,690 patients
Exposure
Nonelective vs elective lower limb revascularization
Outcome
Major amputation and all-cause death after revascularization (illness trajectories)
Methodological detailsMarkov illness-death model, national administrative database
  • Markov illness-death model
  • National administrative database

Main finding

As reported in the abstract

Major amputation · 1 and 5 years after revascularization
GroupAmputation at 1 yearAmputation at 5 years
Nonelective15.2% (95% CI, 14.4-16.0)19.9% (19.0-20.8)
Elective2.7% (95% CI, 2.4-3.1)5.3% (4.9-5.8)

Amputation at 1 year

Nonelective15.2% (95% CI, 14.4-16.0)
Elective2.7% (95% CI, 2.4-3.1)

Amputation at 5 years

Nonelective19.9% (19.0-20.8)
Elective5.3% (4.9-5.8)

Observational data: associations, not effects.

Further findings

OutcomeNonelectiveElective
All-cause mortality · 5 years after revascularization64.3% (95% CI 63.2–65.5)33.0% (95% CI 32.0–34.1)

Mortality after major amputation

Increased mortality risk if major amputation within 6 months after index revascularization

Original publication

Illness Trajectories After Revascularization in Patients With Peripheral Artery Disease: A Unified Approach to Understanding the Risk of Major Amputation and Death. Circulation. Published 22 July 2024. doi:10.1161/circulationaha.123.067687

Summarised from the published abstract; every number is checked against it

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.